Clinical trial / 2013
Oral and intravenous fat loading acutely reduced whole-body insulin sensitivity in healthy adults
In a trial of 16 lean, insulin-sensitive volunteers, participants received oral fat, intravenous fat, intravenous endotoxin, or glycerol control. After 6 hours, whole-body insulin sensitivity was reduced to 67% by oral fat, 60% by intravenous fat, and 48% by endotoxin (all P < 0.01) due to decreased nonoxidative glucose utilization. Muscle protein kinase C-theta activation increased by 50% after oral and intravenous fat, whereas systemic inflammatory markers rose only after endotoxin.
- Study type
- Clinical trial
- Who was studied
- 16 lean, insulin-sensitive volunteers
- What was measured
- Whole-body insulin sensitivity and skeletal muscle signaling
THE PAPER
Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans.
Nowotny B, Zahiragic L, Krog D, Nowotny PJ, Herder C, Carstensen M, Yoshimura T, Szendroedi J, Phielix E, Schadewaldt P, Schloot NC, Shulman GI, Roden M. Diabetes, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.